Insulet Corporation develops insulin delivery systems for people with insulin-dependent diabetes. The companys Omnipod platform includes three products: Omnipod 5, Omnipod DASH, and Omnipod GO. Products are sold through distributors, pharmacies, and directly in various countries.
| Indicator | Value |
|---|---|
| PER | 48.9 |
| EV/EBITDA | 49.3 |
| Price/Free Cash Flow' | 69.1 |
| ROIC | 16.5% |
| Net Debt/EBITDA | 1.0 |